OX40L interactions with OX40+ T cells enhance key signals in adaptive type 2 immunity (61–72), making the OX40L-OX40 signaling axis a promising target for intervention in allergic diseases, including atopic dermatitis (9, 73–75). The gene discussed is TNFRSF4; the disease is atopic eczema.